Bhupinder Bhyan

Mr. Bhupinder Bhyan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2023 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
BBBhupinder Bhyan
Bhupinder Bhyan
DBDinesh Chandra Bhatt
Dinesh Chandra Bhatt
SJSarita Jangra
Sarita Jangra
Objective: Long-lasting migraine pain is one of the most disabling neurological disorders and requires a quick onset of action from the administered dosage form. This study aimed to provide sublingual administration of the frequently used combination of NSAID and triptan in order to trigger their action immediately by escaping the first-pass metabolism, simultaneously improving patient compliance. Methods: In the present research, sublingual bilayer films were developed by joining the two loaded layers with zolmitriptan and piroxicam, respectively. Each layer was prepared and loaded separately using the traditional solvent casting method. Mechanical support was provided by the 1:1 combination of HPMC E-15 and pullulan, which were used as water-soluble film-forming polymers with polyethylene glycol 400 as a plasticizer. Films were evaluated for various physicochemical and mechanical properties. Finally, a pharmacokinetic study was performed on six healthy human volunteers to compare the PK parameters of the best formulation, BSTF-3, with those of a commercially available formulation. Sepitrap 80 and Sepitrap 4000 were used as bio-enhancers to achieve faster systemic delivery. Results: The thin, flexible bilayer films were observed to provide quick action alone with increase patient compliance by preventing the first-pass metabolism and dysphagia. Sepitrap 80 successfully increased the permeation of both drugs. Approximately 92 percent of zolmitriptan was released from the formed bilayer sublingual thin films within 3 min, whereas 92 percent of piroxicam was released within 4.5 min from the best formulation. Within 30 min of the commencement of the pharmacokinetic investigation, plasma concentrations of the active component began to rise rapidly. Conclusion: When compared to commercial formulations, the developed films had a greater AUC and Cmax with a shorter Tmax, indicating a faster trigger of action and higher bioavailability.

11 November 2025
Verified
Book Chapter
Closed access
PDF file
SJSarita Jangra
Sarita Jangra
CVCheppalli Vani
Cheppalli Vani
Amit SharmaAmit Sharma
Amit Sharma
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
BDBhavesh Dharmani
Bhavesh Dharmani
BBBhupinder Bhyan
Bhupinder Bhyan

11 November 2025
Verified
Book Chapter
Closed access
PDF file
CVCheppalli Vani
Cheppalli Vani
SJSarita Jangra
Sarita Jangra
Amit SharmaAmit Sharma
Amit Sharma
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
KSK. A. Shaima
K. A. Shaima
BBBhupinder Bhyan
Bhupinder Bhyan

11 November 2025
Verified
Book Chapter
Closed access
PDF file
SPSalome Satya Vani Punuri
Salome Satya Vani Punuri
SJSarita Jangra
Sarita Jangra
TSThakur Gurjeet Singh
Thakur Gurjeet Singh
Amit SharmaAmit Sharma
Amit Sharma
STSirasani Tapaswi
Sirasani Tapaswi
BBBhupinder Bhyan
Bhupinder Bhyan

25 September 2020 in International Journal of Pharmaceutical Sciences Review and Research
Verified
Journal Article
Open access
SJSarita Jangra
Sarita Jangra
BBBhupinder Bhyan
Bhupinder Bhyan
PNPankaj Singh Negi
Pankaj Singh Negi
SGShubham Gangawat
Shubham Gangawat
IYIndradeep Yadav
Indradeep Yadav

11 November 2025
Verified
Book Chapter
Closed access
PDF file
PVP. Salome Satya Vani
P. Salome Satya Vani
SJSarita Jangra
Sarita Jangra
Amit SharmaAmit Sharma
Amit Sharma
STSirasani Tapaswi
Sirasani Tapaswi
BBBhupinder Bhyan
Bhupinder Bhyan